20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Progyny Inc (PGNY) operates in the HEALTHCARE PLANS industry and is headquartered in New York, United States with about 835 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, PGNY reported $1.3B in revenue and $59M in net income.
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States.
Interactive charts & full statements → Open the PGNY valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.3B | $1.3B | $1.2B | $1.1B | $787M | $501M | $345M | $230M | $105M | $49M |
| Gross Profit | $322M | $304M | $253M | $239M | $167M | $112M | $70M | $46M | $19M | $7M |
| Gross Margin % | 24.6% | 23.6% | 21.7% | 21.9% | 21.3% | 22.4% | 20.3% | 19.8% | 18.4% | 15.2% |
| Operating Income (EBIT) | $112M | $85M | $67M | $62M | $23M | $32M | $8M | $10M | ($3M) | ($11M) |
| Operating Margin % | 8.6% | 6.6% | 5.8% | 5.7% | 3.0% | 6.5% | 2.4% | 4.2% | -3.3% | -22.7% |
| Net Income | $79M | $59M | $54M | $62M | $30M | $66M | $46M | ($9M) | $1M | ($12M) |
| Net Margin % | 6.0% | 4.5% | 4.7% | 5.7% | 3.9% | 13.1% | 13.5% | -3.7% | 0.6% | -25.6% |
| EBITDA | $127M | $100M | $86M | $73M | $26M | $34M | $10M | $12M | ($2M) | ($9M) |
| Earnings Per Share (EPS) | $0.92 | $0.65 | $0.57 | $0.62 | $0.30 | $0.66 | $0.47 | $-0.10 | $0.01 | $-2.19 |
| Shares Outstanding (M) | 82M | 89M | 95M | 101M | 100M | 100M | 99M | 84M | 82M | 6M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $351M | $329M | $318M | $313M | $333M | $324M | $298M | $287M |
| Gross Profit | $89M | $83M | $77M | $73M | $79M | $76M | $63M | $59M |
| Gross Margin % | 25.5% | 25.3% | 24.1% | 23.2% | 23.7% | 23.4% | 21.3% | 20.7% |
| Operating Income (EBIT) | $40M | $35M | $15M | $22M | $24M | $24M | $16M | $12M |
| Operating Margin % | 11.4% | 10.8% | 4.8% | 6.9% | 7.3% | 7.5% | 5.3% | 4.3% |
| Net Income | $28M | $24M | $12M | $14M | $17M | $15M | $11M | $10M |
| Net Margin % | 8.0% | 7.4% | 3.9% | 4.4% | 5.1% | 4.7% | 3.5% | 3.6% |
| EBITDA | $44M | $38M | $19M | $25M | $28M | $28M | $19M | $19M |
| Earnings Per Share (EPS) | $0.34 | $0.29 | $0.14 | $0.15 | $0.19 | $0.17 | $0.11 | $0.11 |
| Shares Outstanding (M) | 82M | 85M | 89M | 90M | 90M | 89M | 95M | 94M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $247M | $210M | $179M | $189M | $80M | $26M | $36M | ($2M) | $2M | ($9M) |
| Capital Expenditures (CapEx) | $29M | $18M | $5M | $4M | $3M | $2M | $1M | $3M | $1M | $1M |
| Free Cash Flow (FCF) | $218M | $192M | $174M | $185M | $77M | $24M | $35M | ($4M) | $2M | ($10M) |
| FCF Margin % | 16.6% | 14.9% | 14.9% | 17.0% | 9.8% | 4.8% | 10.2% | -1.9% | 1.6% | -20.8% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $96M | $46M | $54M | $51M | $56M | $50M | $52M | $45M |
| Capital Expenditures (CapEx) | $13M | $6M | $6M | $5M | $5M | $3M | $2M | $2M |
| Free Cash Flow (FCF) | $84M | $40M | $49M | $46M | $50M | $47M | $50M | $43M |
| FCF Margin % | 23.9% | 12.1% | 15.3% | 14.7% | 15.1% | 14.5% | 16.8% | 14.9% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $716M | $742M | $607M | $757M | $543M | $358M | $254M | $150M | $41M | $35M |
| Cash & Cash Equivalents | $153M | $112M | $162M | $97M | $120M | $91M | $70M | $80M | $0M | $5M |
| Total Liabilities | $263M | $226M | $185M | $203M | $166M | $106M | $87M | $36M | $30M | $24M |
| Total Debt (Short + Long-Term) | $4M | $4M | $3M | $2M | $1M | $1M | $1M | $0M | $0M | $5M |
| Total Shareholders' Equity | $453M | $516M | $422M | $553M | $377M | $252M | $167M | $114M | $11M | $11M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PGNY viewer.
About TickerBase · Data methodology & sources · Privacy · Terms